BIO-CAT implements a new tagline, “Catalyzing Biotech Solutions™.” U.S. Patent 9,555,083 awarded to BIO-CAT for the oral administration of a novel lipase composition to reduce serum triacylglyceride levels in humans.
BIO-CAT implements a new tagline, “Catalyzing Biotech Solutions™.” U.S. Patent 9,555,083 awarded to BIO-CAT for the oral administration of a novel lipase composition to reduce serum triacylglyceride levels in humans.